(Q35193416)

7 August 2017

1 reference

title

Vaccination against measles: a neverending story (English)

1 reference

7 August 2017

1 reference

Rik L de Swart

2

0 references

Ab Osterhaus

series ordinal

3

object named as

Albert D M E Osterhaus

1 reference

7 August 2017

1

Koert J Stittelaar

1 reference

7 August 2017

publication date

1 August 2002

1 reference

Expert Review of Vaccines

7 August 2017

published in

1 reference

7 August 2017

volume

1

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

151-159

1 reference

Eradication of vaccine-preventable diseases

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Differential mortality by measles vaccine titer and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Alternative routes of measles immunization: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

A powder formulation of measles vaccine for aerosol delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Current status and future trends in vaccine regulation--USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Potential advantages and risks of nucleic acid vaccines for infant immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

In vitro processing and presentation of a lipidated cytotoxic T-cell epitope derived from measles virus fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Induction of systemic immune responses to measles virus synthetic peptides administered intranasally

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Enhancement of in vivo and in vitro T cell response against measles virus haemagglutinin after its incorporation into liposomes: effect of the phospholipid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

DNA immunization: effect of secretion of DNA-expressed hemagglutinins on antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: involvement of IFN-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Early studies on DNA-based immunizations for measles virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Recombinant bacille Calmette-Guérin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.1.2.151

21 January 2018

Identifiers

DOI

10.1586/14760584.1.2.151

1 reference

7 August 2017

1 reference